Categories: Research

Desai’s drug delivery research focus of agreement between UCSF and Zcube

Drug delivery research led by UCSF’s Tejal Desai, PhD, will now be supported by an exclusive worldwide license agreement between UCSF and Zcube

Bero represents The Cochrane Collaboration on the World Health Assembly

Lisa Bero, PhD, a faculty member in the UCSF School of Pharmacy was named to represent The Cochrane Collaboration on the World Health Assembly of the World Health Organization (WHO) after the Collaboration was awarded an Assembly

Craik recognized as an AAAS fellow

Charles S. Craik, PhD, a UCSF School of Pharmacy faculty member, has joined the ranks of elected Fellows of the American Association for the Advancement of Science (AAAS).

Fischbach explains his search for antibiotic-producing bacteria in the human gut

The bacteria in the human gut that produce antibiotics are the focus of a US$1 million W. M. Keck Foundation grant being led by Michael Fischbach, PhD, a faculty member in the UCSF School of Pharmacy.

Gartner to lead study on the interactions of cells in breast cancer

Zev Gartner, PhD, a faculty member in the UCSF School of Pharmacy, will lead a US$3.2 million grant to study the interaction of different types of cells in breast cancer at its earliest stages.

New mass spectrometer reveals human proteins in greater detail

A box just four-feet square is the latest addition to the analytical armory of the National Bio-Organic Biomedical Mass Spectrometry Resource Center, which is directed by Al Burlingame, PhD, a faculty member in the Department of Pharmaceutical Chemistry at the UCSF School of P

Reflection: 30 years of top NIH funding for UCSF School of Pharmacy

Table of contents


Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support

Logic gates allow bacteria to work like computers

Logic gates, similar to those that form the basis of silicon computing, can now be inserted into bacteria via genetic engineering, making it possible to manipulate bacteria to perform complicated tasks. This finding will ultimately enable cells to be programmed with more intricate functions,...

SmartPlanet video features The Kidney Project

The implantable bioartificial kidney is explained in this December 6, 2010, SmartPlanet video featuring Shuvo Roy, PhD, a faculty member in the UCSF Schools of Pharmacy and Medicine.

Roy shares promise of bioartificial kidney

Shuvo Roy, PhD, an engineer and research scientist, is leading a U.S. project to build the world’s first bioartificial kidney to treat end stage renal disease. The goal is to surgically implant this coffee-cup-sized device in a human patient within 5 to 7 years.

Pages